A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation-Reference-Cited by-同舟云学术

A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation

Published:2015-06-14 Issue:5 Volume:7 Page:931-945
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Shen Yang,Zeng Lin,Novosyadlyy Ruslan,Forest Amelie,Zhu Aiping,Korytko Andrew,Zhang Haifan,Eastman Scott W,Topper Michael,Hindi Sagit,Covino Nicole,Persaud Kris,Kang Yun,Burtrum Douglas,Surguladze David,Prewett Marie,Chintharlapalli Sudhakar,Wroblewski Victor J,Shen Juqun,Balderes Paul,Zhu Zhenping,Snavely Marshall,Ludwig Dale L

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2015.1055442

Reference45 articles.

1. Bispecific antibodies for cancer therapy

2. Catumaxomab

3. Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response

4. Simultaneous Blockade of Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor Signaling Pathways in Cancer Cells with a Fully Human Recombinant Bispecific Antibody

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment;International Journal of Molecular Sciences;2023-08-21

2. The mechanism of action and biodistribution of a novel EGFR/VEGF bispecific fusion protein that exhibited superior antitumor activities;Heliyon;2023-06

3. A bispecific decoy receptor VEGFR-EGFR/Fc binding EGF-like ligands and VEGF shows potent antitumor efficacy;Journal of Drug Targeting;2021-08-09

4. Significance of Selective Protein Degradation in the Development of Novel Targeted Drugs and Its Implications in Cancer Therapy;Advanced Therapeutics;2020-04-08

5. Modulation of the Biophysical Properties of Bifunctional Antibodies as a Strategy for Mitigating Poor Pharmacokinetics;Biochemistry;2019-06-26